(AP) — Shares of Mead Johnson fell 10 percent Thursday after Wal-Mart
Stores Inc. pulled a batch of its infant formula from more than 3,000
stores when it learned about the death of a newborn.
There
is no known link between the death and the formula and the government
has not ordered a recall of any Enfamil, the brand of powdered formula
that the child consumed. Glenview-based Mead Johnson makes Enfamil.
The
retailer said Wednesday that preliminary tests indicate the newborn
Missouri boy died from a rare bacterial infection, though Mead said its
records showed the lot of formula from which the child was fed tested
negative for the bacterium before it was shipped.
Wal-Mart
said the formula, lot number ZP1K7G, was pulled "out of an abundance of
caution."
Mead Johnson spokesman Christopher Perille said
all the company's infant formula products are put through a battery of
tests as they are produced, packaged and sealed.
Public
health investigators seeking the source of 10-day-old Avery Cornett's
infection will also look at environmental factors, such as the water
used in preparing the powdered formula, and at anything else the baby
might have ingested, Perille said.
Shares of Mead Johnson
Nutrition Co. dropped $7.72 to close at $68.76. Over the past year, the
stock has traded in a range of $55.12 to $76.91.
No comments:
Post a Comment